Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-dige and mass spectrometry

International Journal of Immunopathology and Pharmacology

Volumn 24, Issue 4, 2011, Pages 849-859

  Zhang, J ^a   Song, M Q ^a   Zhu, Jin Shui ^a   Zhou, Z ^a   Xu, Z P ^a   Chen, W X ^a   Chen, N W ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

2D DIGE; Carbonic anhydrase 2; Colorectal cancer; Mass spectrometry; Proteomics; Transgelin

Indexed keywords

ALPHA TROPOMYOSIN; CARBONATE DEHYDRATASE II; CYCLOPHILIN A; METHYLNITROSOUREA; TRANSGELIN; PEPTIDYLPROLYL ISOMERASE; PEPTIDYLPROLYL ISOMERASE A; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CANCER TISSUE; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; FISCHER 344 RAT; FLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; RAT; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING; ENZYME INDUCTION; MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; SUBMUCOSAL INVASIVE COLORECTAL CANCER; SUBMUCOSAL NON INVASIVE COLORECTAL CANCER;

EID: 84863042482     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201102400404     Document Type: Article

References (23)

1. Zell JA. Clinical trials update: Tertiary prevention of colorectal cancer. J Carcinog 2011; 10:8.
2. Fischer M, Yen WC, Kapoun AM, Wang M, O'Young G, Lewicki J, Gurney A, Hoey T. Anti-DLL4 inhibits growth and reduces tumor-initiating cell frequency in colorectal tumors with oncogenic KRAS mutations. Cancer Res 2011; 71:1520-25.
3. Smith K, Malatesti N, Cauchon N, Hunting D, Lecomte R, van Lier JE, Greenman J, Boyle RW. Mono-and tri-cationic porphyrin-monoclonal antibody conjugates: photodynamic activity and mechanism of action. Immunology 2011; 132:256-65.
4. Lam F, Jankova L, Dent OF, et al. Identification of distinctive protein expression patterns in colorectal adenoma. Proteomics Clin Appl 2010; 4:60-70.
5. Li SY, An P, Cai HY, Bai X, Zhang YN, Yu B, Zuo FY, Chen G. Proteomic analysis of differentially expressed proteins involving in liver metastasis of human colorectal carcinoma. Hepatobiliary Pancreat Dis Int 2010; 9:149-53.
6. Friedman DB, Hill S, Keller JW, Merchant NB, Levy SE, Coffey RJ, Caprioli RM. Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics 2004; 4:793-811. (Pubitemid 38339157)
7. Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000; 47:251-55. (Pubitemid 30489769)
8. Tjalsma H. Identification of biomarkers for colorectal cancer through proteomics-based approaches. Expert Rev Proteomics 2010; 7:879-95.
9. Muto T, Taniguchi H, Kushima R, et al. Global expression study in colorectal cancer on proteins with alkaline isoelectric point by two-dimensional difference gel electrophoresis. J Proteomics 2011; 74:858-73.
10. Yeo M, Kim DK, Park HJ, Oh TY, Kim JH, Cho SW, Paik YK, Hahm KB. Loss of transgelin in repeated bouts of ulcerative colitis-induced colon carcinogenesis. Proteomics 2006; 6:1158-65.
11. Lee EK, Han GY, Park HW, Song YJ, Kim CW. Transgelin promotes migration and invasion of cancer stem cells. J Proteome Res 2010; 9:5108-17.
12. Lin Y, Buckhaults PJ, Lee JR, Xiong H, Farrell C, Podolsky RH, Schade RR, Dynan WS. Association of the actin-binding protein transgelin with lymph node metastasis in human colorectal cancer. Neoplasia 2009; 11:864-73.
13. Zhang Y, Ye Y, Shen D, et al. Identification of transgelin-2 as a biomarker of colorectal cancer by laser capture microdissection and quantitative proteome analysis. Cancer Sci 2010; 101:523-9.
14. Lin JL, Geng X, Bhattacharya SD, et al. Isolation and sequencing of a novel tropomyosin isoform preferentially associated with colon cancer. Gastroenterology 2002; 123:152-62. (Pubitemid 34747536)
15. Das KK, Bajpai M, Kong Y, Liu J, Geng X, Das KM. Mesalamine suppresses the expression of TC22, a novel tropomyosin isoform associated with colonic neoplasia. Mol Pharmacol 2009; 76:183-91.
16. Lu H, Goodell V, Disis ML. Targeting serum antibody for cancer diagnosis: a focus on colorectal cancer. Expert Opin Ther Targets 2007; 11:235-44. (Pubitemid 46188816)
17. Yasui Y, Tanaka T. Protein expression analysis of inflammation-related colon carcinogenesis. J Carcinog 2009; 8:10.
18. Luo YX, Cui J, Wang L, et al. Identification of cancer-associated proteins by proteomics and downregulation of β-tropomyosin expression in colorectal adenoma and cancer. Proteomics Clin Appl 2009; 3:1397-406.
19. Bekku S, Mochizuki H, Yamamoto T, Ueno H, Takayama E, Tadakuma T. Expression of carbonic anhydrase I or II and correlation to clinical aspects of colorectal cancer. Hepatogastroenterology 2000; 47:998-1001.
20. Yokoyama S, Shatney CH, Mochizuki H, Hase K, Johnson DL, Cummings S, Trollope ML, Tamakuma S. The potential role of fecal carbonic anhydrase II in screening for colorectal cancer. Am Surg 1997; 63:243-46. (Pubitemid 27133248)
21. Niemelä AM, Hynninen P, Mecklin JP, et al. Carbonic anhydrase IX is highly expressed in hereditary nonpolyposis colorectal cancer. Cancer Epidemiol Biomarkers Prev 2007; 16:1760-66. (Pubitemid 47450505)
22. Kivelä A, Parkkila S, Saarnio J, et al. Expression of a novel transmembrane carbonic anhydrase isozyme XII in normal human gut and colorectal tumors. Am J Pathol 2000; 156:577-84. (Pubitemid 30643813)
23. Kummola L, Hämäläinen JM, Kivelä J, Kivelä AJ, Saarnio J, Karttunen T, Parkkila S. Expression of a novel carbonic anhydrase, CA XIII, in normal and neoplastic colorectal mucosa. BMC Cancer 2005; 5:41.